Yüklüyor......

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence

Poor treatment adherence is problematic in many therapy areas, including multiple sclerosis (MS). Several immunomodulatory drugs are available for the treatment of MS, all of which require frequent parenteral administration. Current first-line therapies are two formulations of interferon (IFN) beta-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Patti, Francesco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819898/
https://ncbi.nlm.nih.gov/pubmed/20165593
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!